| 2018 | | Benefit of Prolonged Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stent for Coronary Bifurcation Lesions: Results From the Coronary Bifurcation Stenting Registry II | 탁승제 |
| 2023 | | Clinical Outcomes of Deferred Lesions by IVUS Versus FFR-Guided Treatment Decision | 윤명호, 탁승제 |
| 2022 | | Effect of Wire Jailing at Side Branch in 1-Stent Strategy for Coronary Bifurcation Lesions | 최소연 |
| 2019 | | Impact of new-onset diabetes on clinical outcomes after ST segment-elevated myocardial infarction | 박진선, 서경우, 서지연, 신준한, 양형모, 윤명호, 임홍석, 최병주, 최소연, 탁승제, 황교승 |
| 2018 | | Importance of prognostic value of neutrophil to lymphocyte ratio in patients with ST-elevation myocardial infarction | 박진선, 서경우, 신준한, 윤명호, 최병주, 최소연, 탁승제, 황교승 |
| 2020 | | Optimal cut-off value of high-sensitivity troponin I in diagnosing myocardial infarction in patients with end-stage renal disease | 이민정, 임은수 |
| 2020 | | Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention With Current-Generation Drug-Eluting Stent | 최소연 |
| 2018 | | Prognostic impact of left ventricular mass change in patients with ST-elevation myocardial infarction | 박진선, 서경우, 신준한, 윤명호, 최병주, 최소연, 탁승제, 황교승 |
| 2023 | | Sustained beneficial effect of β-blockers on clinical outcomes after discontinuation in patients with ST elevation myocardial infarction | 박진선, 서경우, 신준한, 윤명호, 최소연, 황교승 |
